Conferences

Millimeter wave body scanners—standard security measures at airports, train stations and public buildings since the 2000s—are completely safe for heart patients with implantable devices, German researchers reported at last month’s ESC Congress.

Patients hospitalized with endocarditis can be safely switched from intravenous antibiotics to oral medication about halfway through the course of treatment, according to a randomized trial published in the New England Journal of Medicine.

Lorcaserin was associated with significant weight loss among overweight and obese individuals without compromising cardiovascular safety, according to a large, randomized trial published Aug. 26 in The New England Journal of Medicine and presented at the European Society of Cardiology (ESC) Congress in Munich.

A prevalence of left atrial fibrosis in endurance athletes could explain their increased risk for arrhythmias like atrial fibrillation (AFib), according to data presented this week at the European Society of Cardiology (ESC) Congress in Munich.

Late-breaking results of a trial presented at the European Society of Cardiology (ESC)’s 2018 meeting in Munich suggest a removable balloon is as effective as a permanent stent in unblocking small arteries. 

Late-breaking results from the VISION study, presented early this week at the European Society of Cardiology (ESC)’s annual symposium, found nearly three-quarters of patient deaths after noncardiac surgery can be attributed to cardiovascular causes.

Preliminary results from a European Society of Cardiology (ESC) poll suggest the best long-term investment medical institutions can make is in their own employees, whose risk for burnout could be mitigated by more dynamic, supportive work environments where they feel valued.

Cardiac patients diagnosed with “broken heart syndrome” are twice as likely to run into clinical complications during treatment if they have a history of cancer, Italian researchers reported this week at the ESC Congress in Munich.

Research presented this week at the European Society of Cardiology Congress in Munich suggests a new treatment may be emerging for transthyretin amyloid cardiomyopathy—a condition previously thought to be rare and untreatable.

Major cardiology associations joined forces to define and standardize what exactly constitutes a heart attack, differentiating between myocardial infarction (MI) and “myocardial injury” while offering guidance on how to incorporate emerging imaging techniques and high-sensitivity troponin assays.

Combining oral anticoagulants with antiplatelet therapy in atrial fibrillation (AFib) patients could be more than just overkill, University of Edinburgh researchers reported at the European Society of Cardiology’s annual meeting this month. It could be dangerous, increasing the risk for all-cause death, stroke and major bleeding events in those without an indication for dual treatment.

Despite its relative rarity in clinical practice, the Ross procedure provides a survival benefit over mechanical aortic valve replacement in young and middle-aged patients, suggests a meta-analysis published in JAMA Cardiology and presented at the European Society of Cardiology (ESC) Congress in Munich.